Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
Saphnelo (anifrolumab) - AstraZeneca
Pregnancy (LUPUS-KCR 2023) - May 20, 2023 - Pres time: May 17, 2023; 01:50 PM - 02:10 PM; Location: Grand Ballroom 102; "Furthermore, we will discuss the use of therapeutic drug monitoring to optimize pregnancy outcomes in SLE. Moreover, we will consider potential strategies for active surveillance of drug safety in pregnancy for newly approved medications (i.e. belimumab, voclosporin, anifrolumab) and the need for more research on pregnancy termination in SLE." 
Cardiovascular • Gynecology • Hypertension • Immunology • Inflammatory Arthritis
https://www.lupus-kcr2023.org/program/02.html?dateIdx=&sch_txt=&searchLupusCate=0&searchKcrCate=0
 
Evelyne Vinet
 
May 20, 2023
 
Prev Next